July. The quietest honest moment in the practice calendar. The January resolutions are long gone, the year-end panic hasn’t started, and you’re sitting on six months of real data about how your practice actually performs. Not how you hoped it would perform when you sketched out plans over Christmas. How it actually did.
Most independent optician owners never look at that data. They’ll glance at the bank balance, feel vaguely better or worse than last month, and carry on. Then December arrives and the year’s story gets written by default rather than by decision.
This post is the alternative. A proper mid-year review takes one quiet afternoon, and it’s worth more than any January plan you’ll ever write. Here’s how to run one, what to pull, what to ask, and how to turn it into a second half that looks different from the first.
Why mid-year beats January
January planning has a flaw nobody talks about. You’re planning with stale data, zero momentum, and a full twelve months of distance between the plan and the deadline. It’s the easiest plan in the world to abandon because the consequences feel so far away.
A July review is different in three ways.
First, the data is fresh and complete. Six months is long enough to smooth out the noise of a bad week or a freak month, and recent enough that you remember why the numbers look the way they do.
Second, the deadline is real. Whatever you decide in July has to survive only five months of execution before you can judge it. That proximity keeps decisions honest and small enough to actually do.
Third, you can still change the year. A practice that’s tracking 8% behind where it wants to be can close that gap in a focused second half. In November it can’t. The mid-year review is the last point in the year where the steering wheel still turns the car.
The backdrop: nobody is coming to save the margin
Before the numbers, a quick dose of context, because the environment matters for what you decide.
The NHS settlement for this cycle moved the GOS sight test fee in England to £24.13. That’s a 60p rise, below inflation, with voucher values and most other payments frozen. The professional bodies made the case for at least £25 and were turned down on affordability grounds. Whatever your view on the politics, the practical read for a practice owner is simple: the funded side of your practice will keep shrinking in real terms, and no fee letter is going to fix your margin for you.
Meanwhile the wider market keeps consolidating. The UK opticians industry is worth around £5.8bn in 2026, but the independent share of it has slid from roughly 35% to 25% over the past decade. The independents who are thriving inside that shrinking share aren’t doing it by working longer days. They’re doing it by running tighter practices, keeping their patient base active, and making more of every patient relationship they already have.
That’s exactly what a mid-year review is for.
Step one: pull the numbers (90 minutes, not a weekend)
You don’t need a finance degree and you don’t need every metric. You need the handful that describe the health of the machine. Pull each one for January to June 2026, and put last year’s same six months next to it if you have them.
The money
Total revenue, split between clinical fees and dispensing. Then average transaction value on dispenses. If revenue is flat but ATV is up, you have a footfall problem. If revenue is flat and ATV is down, you have a conversion or pricing problem. Same headline, opposite fixes, and you can’t tell them apart without the split. If your billing and finance reporting can’t give you this split in a few clicks, that’s a finding in itself.
The diary
Test volume, DNA rate, and how far ahead the diary is booked. A DNA rate creeping above 5-6% is quietly deleting clinical capacity you’re paying for either way. A diary booked out three weeks ahead sounds healthy but often hides lost demand, because some patients won’t wait and you’ll never know they called.
The conversion
Dispense rate: of the patients who had an eye test, how many bought? This single number moves more revenue than almost anything else in the practice, and most owners can’t say what theirs is. Even a rough version, dispenses divided by tests, tells you plenty.
The patient base
Recall completion is the big one. Of the patients due back in the first half of the year, how many actually came? Anything under 70% means your most valuable asset, the patient database you’ve spent years building, is leaking quietly out of the back of the practice while you worry about new patients coming in the front. New patient numbers matter too, but recall is cheaper, warmer, and entirely within your control.
The drawer
Count the uncollected spectacles and unpaid balances sitting in the practice right now. It’s the fastest cash you’ll find all year.
That’s it. Eight or nine numbers. If pulling them takes more than a morning because they live in three systems and a paper diary, write that down too, because slow numbers are one of the reasons practices drift.
Step two: ask three questions of what you find
Data doesn’t make decisions. These three questions do.
1. What actually worked?
Not what you enjoyed, what worked. Which months beat last year, and what was different about them? Which service made money without drama? If your contact lens direct debit base grew or your recall push in March filled April’s diary, that’s a signal. The cheapest growth in H2 is doing more of what already worked in H1, deliberately instead of accidentally.
2. Where did it leak?
Every practice leaks in the same few places: patients who never rebooked, tests that didn’t convert to a dispense, glasses that sat uncollected, hours of clinic lost to DNAs. Put a rough monthly value on your biggest leak. A practice doing 60 tests a week with a dispense rate five points below where it should be is losing more every month than most spend on marketing in a year. Fix the leak before you buy more water.
3. What did you tolerate?
This is the uncomfortable one. The staff member everyone works around. The pricing you haven’t touched since 2023 despite every cost rising. The “temporary” workaround in your admin that’s now permanent. The software you complain about every week but renew every year. Mid-year is the right time to name these, because you have five months to fix them while it still counts.
Step three: pick three moves. Not ten. Three.
The most common failure mode of any review is the fifteen-point action plan that dies within a fortnight. Momentum beats ambition. Choose a maximum of three moves for the second half, and make them the three with the shortest line to money or time.
Some candidates, in rough order of how quickly they pay:
Clear the drawer. Run a structured chase on every uncollected pair and unpaid balance. Days to do, immediate cash.
Rebuild one recall cycle properly. Pick the patients who went overdue in H1 and run a real sequence: SMS, then a different channel, then a human call for high-value patients. An automated recall system makes this a setting rather than a project, but even done manually it outearns almost any ad spend.
Fix the handover that’s costing you dispenses. If your dispense rate is the leak, the fix is usually the walk from the test room to the dispensing desk, not the frames on the wall.
Reprice with a straight face. If your private fees and professional charges haven’t moved while the GOS fee lost ground to inflation again, you’ve taken a pay cut by default. Small, confident increases on clearly communicated services almost never produce the patient exodus owners fear.
Kill one tolerated thing. Whatever came up under question three. One, properly dealt with, beats three half-confronted.
Write the three moves down, give each one an owner and a date, and put a thirty-minute check-in in the diary for the first week of September and the first week of November. That’s the entire governance structure a small practice needs.
The mistakes that undo mid-year reviews
Turning it into a strategy retreat. You’re not rewriting the vision. You’re reading six months of evidence and adjusting. Keep it to an afternoon.
Only looking at revenue. Revenue is a lagging result of the operational numbers, recall, DNA, dispense rate, that you can actually pull levers on. Review the levers, not just the outcome.
Benchmarking against your hopes. Compare against last year’s actuals, not January’s optimism. The question is whether the practice is getting better, not whether it hit a number you invented in a quiet week.
Doing it once. A review with no September check-in is a diary entry, not a decision. The follow-up is where the value lives.
Where your software earns its keep
Here’s the quiet test hidden inside this whole exercise: how hard was it to get the numbers?
If your practice management system produced revenue splits, dispense rate, recall completion and DNA rate in a few minutes, the review is easy and you’ll do it again. If the afternoon disappeared into exporting spreadsheets and cross-referencing a paper diary, the system is taxing every good decision you try to make.
This is much of why we built Raven Vision inside working practices before selling it to anyone. Shaukat, our co-founder, has run his own practices for over three decades, and the reporting exists because he needed these exact answers on a Tuesday afternoon, not at year-end. The patient management system keeps recall status, visit history and dispense outcomes on one record, so “who went overdue in H1?” is a filter, not a project. And because it’s £149 a month with everything included, the software line on your cost review stays a short conversation.
If your current system failed the mid-year test, that’s worth acting on while there’s still a second half to benefit. You can see exactly what’s included in the pricing, or book a demo and we’ll show you the H1 review reports on real screens, running on your kind of practice.
The year is still yours to decide
Six months of evidence, three honest questions, three moves, two check-ins. That’s the whole method.
The independents who end 2026 stronger than they started it won’t be the ones who worked the most Saturdays. They’ll be the ones who stopped in July, read what the first half was telling them, and chose the second half on purpose. The market backdrop is what it is: a real-terms fee cut, a consolidating high street, and a shrinking independent share held by practices that run deliberately. You can’t control any of that. The afternoon with the numbers, you can.
Book the afternoon. This week, before the summer swallows it.
